Acorda Therapeutics, Inc.
ACOR
Clasificación en acciones
#39157
Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering,... Acorda Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and commercializing treatments for conditions affecting the nervous system, primarily within the United States. Its current product offerings include Ampyra (dalfampridine), an oral medication prescribed to enhance walking ability in individuals with multiple sclerosis (MS). The company also distributes Inbrija in Europe, which is used to manage "OFF" periods experienced by Parkinson's disease patients. Globally, Ampyra is recognized and sold as Fampyra across Europe, Asia, and the Americas. Beyond its existing products, Acorda is actively advancing several experimental therapies: ARCUS for the management of acute migraine attacks, rHIgM22 which has successfully completed Phase I clinical trials for MS, and Cimaglermin alfa, currently being investigated for patients with heart failure. The company holds a licensing and collaborative agreement with Biogen Inc. for the ongoing development and market distribution of Ampyra. Acorda Therapeutics, Inc. was founded in 1995 and operates from its headquarters in Ardsley, New York.
Precio por acción
$0.879
Última sincronización: 2024-05-07
Capitalización bursátil
$582.38K
Cambio (1 día)
9.88%
Cambio (1 año)
8,690.00%
País
US
Comercio Acorda Therapeutics, Inc. (ACOR)
Categoría
Healthcare
Margen Operativo de Acorda Therapeutics, Inc. (ACOR)
Margen Operativo al October 2026 TTM: -19.78%
Según los informes financieros más recientes y el precio de las acciones de Acorda Therapeutics, Inc., el margen operativo actual (TTM) es -19.78%. Al final de 2022, el margen operativo era -35.45%.
Historial de Margen Operativo de Acorda Therapeutics, Inc. desde 2003 hasta 2026
Margen Operativo al final de cada año
| Año | Margen Operativo | Cambiar |
|---|---|---|
| 2026 (TTM) | -19.78% | 0.00% |
| 2023 | -19.78% | -44.20% |
| 2022 | -35.45% | -40.81% |
| 2021 | -59.89% | 5.42% |
| 2020 | -56.81% | -851.46% |
| 2019 | 7.56% | -7.35% |
| 2018 | 8.16% | -120.62% |
| 2017 | -39.57% | 471.82% |
| 2016 | -6.92% | -200.29% |
| 2015 | 6.90% | -23.84% |
| 2014 | 9.06% | 0.33% |
| 2013 | 9.03% | 7.89% |
| 2012 | 8.37% | -30.25% |
| 2011 | 12.00% | -372.11% |
| 2010 | -4.41% | -97.03% |
| 2009 | -148.63% | -3.20% |
| 2008 | -153.55% | 53.70% |
| 2007 | -99.90% | 16.43% |
| 2006 | -85.80% | -87.17% |
| 2005 | -668.73% | -92.84% |
| 2004 | -9,336.26% | 27.91% |
| 2003 | -7,298.95% | 0.00% |
Margen Operativo de empresas similares o competidoras
| Empresa | Margen Operativo | Diferencia de Margen Operativo | País |
|---|---|---|---|
| 0.00% | - |
DE
|
|
| 0.00% | - |
DE
|
|
| 0.00% | - |
JP
|
|
| 0.00% | - |
CH
|
|
| 22.93% | -101.16% |
IN
|
¿Qué es el Margen Operativo de una empresa?
El Margen Operativo es un indicador clave para evaluar la rentabilidad de una empresa. Un margen operativo más alto suele ser mejor, ya que indica que una empresa puede vender sus productos o servicios por mucho más de lo que cuestan producirlos. Se calcula dividiendo las ganancias de la empresa entre sus ingresos.